German National Registry for NSS
1 other identifier
observational
1,000
1 country
5
Brief Summary
The G-NeSS Registry prospectively collects data on clinical and outcome variables from patients undergoing partial nephrectomy for renal masses. Analyses of data aims at identifying key factors determining the quality of surgical care in this patient population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2020
Longer than P75 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 9, 2020
CompletedStudy Start
First participant enrolled
December 15, 2020
CompletedFirst Posted
Study publicly available on registry
December 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 15, 2027
January 29, 2025
January 1, 2025
5.8 years
September 9, 2020
January 27, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Complication rate
Complication rate according to Clavien-Dindo in %
60 months
Postoperative glomerular inflitration rate
Rate in ml/min.
60 months
Survival
Overall Survival
60 months
Interventions
Observation only
Eligibility Criteria
Patients with a renal mass eligible for partial nephrectomy
You may qualify if:
- Age ≥ 18 years
- Written informed consent
- Localized renal parenchymal mass amenable to nephron-sparing surgery
- Adequate imaging of the abdomen (CT or MR with contrast)
You may not qualify if:
- Patient with (or suspected to have) urothelial cancer of the kidney
- Prior nephron-sparing surgery on ipsilateral kidney
- metastasized renal cell carcinoma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Sana Klinikum Hof
Hof, Bavaria, 95032, Germany
MHH
Hanover, Lower Saxony, 30625, Germany
Alexianer St. Hedwig-Krankenhaus
Berlin, 10115, Germany
Vivantes Humboldt Klinikum
Berlin, Germany
Saarland University
Homburg/Saar, 66421, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Nina Harke, Dr.
MHH
- STUDY CHAIR
Stefan Siemer, Prof. Dr.
University Saarland
- STUDY CHAIR
Steffen Weikert, Prof. Dr.
Vivantes Humboldt-Klinikum
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 60 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2020
First Posted
December 23, 2020
Study Start
December 15, 2020
Primary Completion (Estimated)
September 15, 2026
Study Completion (Estimated)
September 15, 2027
Last Updated
January 29, 2025
Record last verified: 2025-01